Contineum Therapeutics, Inc. Class A Common Stock(CTNM:US)

Market Cap$266.3M

Key Metrics

Price$7.08

Revenue (TTM)$0

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$57.56M

EBITDA (TTM)-$66M

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$14.71M

Total Assets$250.37M

Net Assets$239.66M

Total Debt$6.57M

Contineum Therapeutics, Inc. Class A Common Stock(CTNM:US)

Market Cap$266.3M

Price history

Key Metrics

Price$7.08

Revenue (TTM)$0

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$57.56M

EBITDA (TTM)-$66M

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$14.71M

Total Assets$250.37M

Net Assets$239.66M

Total Debt$6.57M

Financials

NameJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Revenue
$0$0$0$0$0$0$0$0$0$0$0$0$50M$0$0
Cost of Revenue
---------------
Gross Profit
---------------
$17.43M$16.9M$17.12M$14.93M$17.9M$18.11M$17.05M$12.97M$10.94M$9.93M$9.68M$8.07M$11.06M$5.12M$5.45M
Research and Development$12.7M$11.65M$12.76M$10.99M$14.06M$13.71M$13.02M$9.73M$7.9M$7.78M$8.01M$6.5M$9.46M$3.63M$3.95M
Selling, General, and Administrative$4.73M$5.26M$4.36M$3.94M$3.84M$4.4M$4.03M$3.25M$3.04M$2.15M$1.66M$1.57M$1.6M$1.48M$1.5M
Other Operating Expenses---------------
Operating Income
-$17.43M-$16.9M-$17.12M-$14.93M-$17.9M-$18.11M-$17.05M-$12.97M-$10.94M-$9.93M-$9.68M-$8.07M$38.94M-$5.12M-$5.45M
$2.27M$2.45M$1.96M$2.14M$1.86M$2.12M$2.48M$2.71M$1.94M$1.51M$1.75M$1.7M$3.36M$291K-$2.06M
Non-Operating Interest Income$2.34M$2.51M$2.01M$1.96M$2.03M$2.25M$2.53M$2.74M$2M$1.64M$1.79M$1.74M$679K$401K$342K
Non-Operating Interest Expense------$0$0$0$0$0$0$116K$92K$101K
Other Income/Expense-$68K-$57K-$51K$183K-$167K-$130K-$46K-$34K-$66K-$123K-$44K-$36K$2.79M-$18K-$2.3M
Income Before Tax
-$15.15M-$14.46M-$15.16M-$12.79M-$16.04M-$15.99M-$14.57M-$10.27M-$9.01M-$8.42M-$7.93M-$6.37M$42.29M-$4.82M-$7.51M
Income Tax
------$0$0$0$0-$161K-$118K$729K$0-
Net Income
-$15.15M-$14.46M-$15.16M-$12.79M-$16.04M-$15.99M-$14.57M-$10.27M-$9.01M-$8.42M-$7.77M-$6.25M$41.56M-$4.82M-$7.51M
Minority Interests
---------------
Preferred Stock Dividends
-------$0$0--$0$35.7M--
Net Income to Common
-$15.15M-$14.46M-$15.16M-$12.79M-$16.04M-$15.99M-$14.57M-$10.27M-$9.01M-$8.42M-$7.77M-$6.25M$5.87M-$4.82M-$7.51M
Shares Outstanding (Basic)
37.47M37.34M30.86M28.12M25.9M25.87M25.82M25.73M23.36M27.06M-27.06M16.67M16.67M-
Shares Outstanding (Diluted)
37.47M37.34M30.86M28.12M25.9M25.87M25.82M25.73M23.36M27.06M-27.06M17.76M17.76M-
EPS (Basic)
-$0.40-$0.39-$0.49-$0.45-$0.62-$0.62-$0.56-$0.40-$0.39-$0.31--$0.23$0.35-$0.29-
EPS (Diluted)
-$0.40-$0.39-$0.49-$0.45-$0.62-$0.62-$0.56-$0.40-$0.39-$0.31--$0.23$0.17-$0.29-
EBIT
-$17.43M-$16.9M-$17.12M-$14.93M-$17.9M-$18.11M-$14.57M-$10.27M-$9.01M-$8.42M-$7.93M-$6.37M$42.41M-$4.73M-$7.41M
EBITDA
-$17.29M-$16.82M-$17.03M-$14.85M-$17.82M-$18.03M-$14.49M-$10.21M-$8.96M-$8.24M-$7.9M-$6.33M$39.58M-$4.66M-$5.04M